The U.S. Food and Drug Administration recently announced that it will not object to specific health claims regarding yogurt and its potential impact on type 2 diabetes.

Enforcement Discretion from the FDA

In a letter detailing enforcement discretion, the FDA outlined its willingness to approve certain qualified health claims concerning yogurt consumption and the reduced risk of type 2 diabetes. These claims must be worded in a manner that ensures they are not misleading to consumers.

Qualified Health Claims Explained

Petition from Danone North America

Danone North America was responsible for submitting a petition requesting approval for these health claims. The FDA's decision was influenced by the evidence presented, indicating a credible connection between yogurt intake and a decreased risk of type 2 diabetes.

Limited Evidence, Promising Results

While the evidence supporting this relationship is limited, it points to a potential benefit worth exploring further. Miguel Freitas, vice president of health and scientific affairs at Danone North America, highlighted the importance of this development in light of the growing body of research.

This decision marks a significant step in acknowledging the potential health benefits of regular yogurt consumption, especially concerning a prevalent health issue in the United States.

Leave Comment